Aptus Pharma Limited (BOM:544529)
India · Delayed Price · Currency is INR 339.90
+6.65 (2.00%)
At close: Sep 11, 2026
Aptus Pharma Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 10.27 | 52.14 | 9.14 | 5.37 | 2.61 |
Cash & Short-Term Investments | 10.27 | 52.14 | 9.14 | 5.37 | 2.61 |
Cash Growth | -80.30% | 470.20% | 70.41% | 105.97% | 249.19% |
Accounts Receivable | 187.6 | 56.39 | 33.54 | 23.98 | 18.5 |
Receivables | 189.49 | 59.3 | 37.82 | 27.65 | 18.86 |
Inventory | 135.69 | 70.58 | 34.26 | 22.99 | 13.94 |
Prepaid Expenses | 0.44 | 1.31 | 0.37 | 0.23 | 0.2 |
Other Current Assets | 16.47 | 14.03 | 1.63 | 0.29 | 0.65 |
Total Current Assets | 352.36 | 197.36 | 83.22 | 56.52 | 36.25 |
Property, Plant & Equipment | 26.94 | 9.63 | 6.17 | 5.14 | 3.47 |
Long-Term Investments | - | - | 10.06 | - | - |
Other Intangible Assets | 0.75 | 0.28 | 0 | 0 | 0 |
Long-Term Deferred Tax Assets | 0.92 | 0.74 | 0.56 | 0.36 | 0.19 |
Other Long-Term Assets | 54.38 | 11.2 | 0.09 | 0.09 | 0.09 |
Total Assets | 435.35 | 219.2 | 100.1 | 62.11 | 40 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 81.53 | 13.09 | 18.45 | 25.78 | 9.11 |
Accrued Expenses | 14.07 | 11.9 | 2.63 | 1.51 | 0.32 |
Short-Term Debt | 64.47 | 66.37 | 9.91 | - | - |
Current Portion of Long-Term Debt | 2.13 | 11 | 3.57 | 2.05 | 1.92 |
Current Income Taxes Payable | 17.02 | 11.17 | 3.14 | 1.05 | 0.51 |
Other Current Liabilities | 13.84 | 7.31 | 3.26 | 0.7 | 8.96 |
Total Current Liabilities | 193.06 | 120.84 | 40.97 | 31.09 | 20.81 |
Long-Term Debt | 5.22 | 26.2 | 39.6 | 20.07 | 10.67 |
Pension & Post-Retirement Benefits | 3.61 | 2.5 | - | - | - |
Total Liabilities | 201.89 | 149.54 | 80.56 | 51.16 | 31.48 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 68.6 | 50 | 3 | 3 | 3 |
Additional Paid-In Capital | 107 | 8 | 3.5 | 3.5 | - |
Retained Earnings | 57.86 | 11.66 | 13.04 | 4.44 | 5.52 |
Shareholders' Equity | 233.46 | 69.66 | 19.54 | 10.94 | 8.52 |
Total Liabilities & Equity | 435.35 | 219.2 | 100.1 | 62.11 | 40 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 71.82 | 103.57 | 53.08 | 22.12 | 12.58 |
Net Cash (Debt) | -61.55 | -51.43 | -43.94 | -16.75 | -9.98 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -4.15 | -4.23 | -11.71 | -9.17 | -5.46 |
Filing Date Shares Outstanding | 17.15 | 12.5 | 3.75 | 3.75 | 3.75 |
Total Common Shares Outstanding | 17.15 | 12.5 | 3.75 | 3.75 | 3.75 |
Working Capital | 159.3 | 76.53 | 42.26 | 25.43 | 15.44 |
Book Value Per Share | 13.61 | 5.57 | 5.21 | 2.92 | 2.27 |
Tangible Book Value | 232.71 | 69.39 | 19.54 | 10.94 | 8.51 |
Tangible Book Value Per Share | 13.57 | 5.55 | 5.21 | 2.92 | 2.27 |
Buildings | 10.31 | 0.88 | - | - | - |
Machinery | 29.15 | 17.34 | 12.15 | 8.99 | 5.52 |